Literature DB >> 26965543

Pharmacometabolomics Meets Genetics: A "Natural" Clinical Trial of Statin Effects.

Deepak Voora1, Svati H Shah2.   

Abstract

Keywords:  cardiovascular disease; lipids; pleiotropic effects; target

Mesh：

Substances：

Year:  2016        PMID： 26965543     DOI： 10.1016/j.jacc.2016.01.022

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  6 in total

1.  Harnessing the Power of Pharmacometabolomics: The Metabolic Footprint of Statins.

Authors:  Jennifer E Ho
Journal:  Circ Cardiovasc Genet       Date:  2017-12

2.  Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas.

Authors:  Jun Liu; Lies Lahousse; Michel G Nivard; Mariska Bot; Lianmin Chen; Jan Bert van Klinken; Carisha S Thesing; Marian Beekman; Erik Ben van den Akker; Roderick C Slieker; Eveline Waterham; Carla J H van der Kallen; Irene de Boer; Ruifang Li-Gao; Dina Vojinovic; Najaf Amin; Djawad Radjabzadeh; Robert Kraaij; Louise J M Alferink; Sarwa Darwish Murad; André G Uitterlinden; Gonneke Willemsen; Rene Pool; Yuri Milaneschi; Diana van Heemst; H Eka D Suchiman; Femke Rutters; Petra J M Elders; Joline W J Beulens; Amber A W A van der Heijden; Marleen M J van Greevenbroek; Ilja C W Arts; Gerrit L J Onderwater; Arn M J M van den Maagdenberg; Dennis O Mook-Kanamori; Thomas Hankemeier; Gisela M Terwindt; Coen D A Stehouwer; Johanna M Geleijnse; Leen M 't Hart; P Eline Slagboom; Ko Willems van Dijk; Alexandra Zhernakova; Jingyuan Fu; Brenda W J H Penninx; Dorret I Boomsma; Ayşe Demirkan; Bruno H C Stricker; Cornelia M van Duijn
Journal:  Nat Med       Date:  2020-01-13       Impact factor: 53.440

3.  Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge?

Authors:  Mika Ala-Korpela; George Davey Smith
Journal:  Int J Epidemiol       Date:  2016-10-27       Impact factor: 7.196

Review 4.  Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future.

Authors:  Naomi J Rankin; David Preiss; Paul Welsh; Naveed Sattar
Journal:  Int J Epidemiol       Date:  2016-10-27       Impact factor: 7.196

5.  Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment

Authors:  Naveed Sattar; Adam Butterworth; Peter Würtz; Eeva Sliz; Johannes Kettunen; Michael Holmes; Clare Williams; Charles Boachie; Qin Wang; Minna Männikkö; Sylvain Sebert; Robin Walters; Kuang Lin; Lona Millwood; Robert Clarke; Liming Li; N Rankin; Paul Welsh; Christian Delles; J Jukema; Stella Trompet; Ian Ford; Markus Perola; Veikko Salomaa; Marjo-Riitta Järvelin; Zhengming Chen; Debbie Lawlor; Mika Ala-Korpela; John Danesh; George Smith
Journal:  Circulation       Date:  2018-11-27       Impact factor: 29.690

Review 6.  Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.

Authors:  Peter Würtz; Antti J Kangas; Pasi Soininen; Debbie A Lawlor; George Davey Smith; Mika Ala-Korpela
Journal:  Am J Epidemiol       Date:  2017-11-01       Impact factor: 4.897
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.